This is a routine, small-proportional director sale with no material signal. Monitor for any follow-on Form 4 filings to confirm execution, but no trading action is warranted based on this filing alone.
Price Chart
Executive Summary
Director Dino A. Rossi filed a Form 144 notice of intent to sell 25,000 shares of Krystal Biotech common stock through Goldman Sachs, with an estimated aggregate market value of approximately $8.3 million based on the filing date. This represents about 0.08% of the company's $9.7B market cap and a modest portion of Rossi's total holdings of ~29.6 million shares. The sale is routine for a director and does not signal insider concern given the small proportional size and the company's strong institutional support (89% analyst bullish).
Key Facts
- Director Dino A. Rossi filed Form 144 to sell 25,000 shares of KRYS common stock.
- Estimated aggregate market value of the proposed sale is approximately $8.3 million.
- Rossi holds approximately 29.6 million shares post-sale, making this a ~0.08% reduction in his position.
- The shares were acquired from the public market on 09/22/2017, indicating long-term holding.
- Sale is to be executed through Goldman Sachs & Co. LLC.
Financial Impact
Proposed sale of 25,000 shares valued at ~$8.3 million, representing ~0.08% of KRYS's $9.7B market cap.
Risk Factors
- Insider may still decide not to execute the sale despite filing the notice.
- No material risk to the company's fundamentals or stock price from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001958244-26-000513 |
| Document: 0001958244-26-000513-index.html | 0001958244-26-000513 |
| Document: 0001958244-26-000513.txt | 0001958244-26-000513 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Insider Cluster | $351.26 $336.68 | ▲ +4.15% | ▲ +3.03% | $322.28 (+8.25%) |
Aug 14, 2026 7w ago | 144 | $335.73 $341.72 | ▲ +1.78% | ▲ +2.97% | $322.28 (−4.01%) |
Aug 3, 2026 8w ago | 8-K | $312.57 $331.59 | ▲ +6.08% | ▲ +4.06% | $322.28 (+3.11%) |
Jul 23, 2026 10w ago | Press Release | $335.19 $366.85 | ▲ +9.45% | ▲ +9.07% | $322.28 (−3.85%) |
Jun 5, 2026 17w ago | Insider Cluster | $301.76 $324.75 | ▲ +7.62% | ▲ +5.51% | $322.28 (+6.80%) |
May 4, 2026 21w ago | Press Release | $286.95 $312.88 | ▲ +9.04% | ▲ +6.10% | $322.28 (+12.31%) |
Apr 21, 2026 23w ago | Press Release | $272.66 $269.27 | ▼ −1.24% | ▼ −2.33% | $322.28 (+18.20%) |
Apr 3, 2026 26w ago | DEFA14A | $261.80 $267.41 | ▲ +2.14% | ▼ −1.99% | $322.28 (+23.10%) |
Feb 27, 2026 31w ago | Insider Cluster | $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $322.28 (+16.92%) |
Feb 27, 2026 31w ago | Insider Cluster | $275.64 $253.69 | ▼ −7.96% | ▼ −5.98% | $322.28 (+16.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access